Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 1 (2004), Issue 5 (December)

1. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
   J Natl Cancer Inst, 96(23): 1790-3. [Abstract] [Full-text]
2. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients.
   Eur J Cancer, 40(18): 2812-9. [Abstract] [Full-text]
3. The importance of assessing the readiness to change sun-protection behaviours: a population-based study.
   Eur J Cancer, 40(18): 2773-80. [Abstract] [Full-text]
4. Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
   Cancer Res, 64(23): 8773-7. [Abstract] [Full-text]
5. Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
   Cancer Res, 64(23): 8767-72. [Abstract] [Full-text]
6. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
   Cancer Res, 64(23): 8573-84. [Abstract] [Full-text]
7. Metastatic myoepithelioma of the breast.
   ANZ J Surg, 74(12): 1135-7. [Abstract] [Full-text]
8. Primary cutaneous extraskeletal osteosarcoma under a previous electrodessicated actinic keratosis.
   J Am Acad Dermatol, 51(5): S166-8. [Abstract] [Full-text]
9. Primary carcinoid tumor of the skin.
   J Am Acad Dermatol, 51(5): S146-8. [Abstract] [Full-text]
10. Melanoma and lifetime UV radiation.
    Cancer Causes Control, 15(9): 893-902. [Abstract] [Full-text]
11. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
    Ann Surg Oncol, 11(12): 1079-84. [Abstract] [Full-text]
12. An unusual cutaneous lesion as the presenting sign of spinal dysraphism in a preterm infant.
    Pediatr Dermatol, 21(6): 664-6. [Abstract] [Full-text]
13. Lymphangioma circumscriptum: an example of Whimster's hypothesis.
    Pediatr Dermatol, 21(6): 652-4. [Abstract] [Full-text]
14. Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome?
    J Am Acad Dermatol, 51(6): 989-95. [Abstract] [Full-text]
15. Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study.
    J Am Acad Dermatol, 51(6): 923-30. [Abstract] [Full-text]
16. Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis.
    J Am Acad Dermatol, 51(6): 919-22. [Abstract] [Full-text]
17. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
    Ophthalmology, 111(12): 2151-7. [Abstract] [Full-text]
18. What influences university students' intentions to practice safe sun exposure behaviors?
    J Adolesc Health, 35(6): 486-92. [Abstract] [Full-text]
19. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.
    JAMA, 292(22): 2771-6. [Abstract] [Full-text]
20. Fine-needle aspiration cytology of lipoblastoma: a report of two cases.
    Diagn Cytopathol, 32(1): 32-4. [Abstract] [Full-text]
21. Fine mapping of chromosome 10q deletions in mycosis fungoides and sezary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1.
    Genes Chromosomes Cancer, 42(2): 184-92. [Abstract] [Full-text]
22. Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.
    Ann Oncol, 16(1): 162-8. [Abstract] [Full-text]
23. Phase II study of E7070 in patients with metastatic melanoma.
    Ann Oncol, 16(1): 158-61. [Abstract] [Full-text]
24. Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms.
    Ann Hum Genet, 68: 536-45. [Abstract] [Full-text]
25. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.
    Genes Dev, 18(24): 2998-3003. [Abstract] [Full-text]
26. Digital syndactylization for the treatment of interdigital squamous cell carcinoma in situ (Bowen disease).
    J Foot Ankle Surg, 43(6): 419-22. [Abstract] [Full-text]
27. Polymorphous vascular patterns in dermoscopy as a sign of malignant skin tumors. A case of an amelanotic melanoma and a porocarcinoma.
    Dermatology, 210(1): 58-9. [Abstract] [Full-text]
28. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
    Dermatology, 210(1): 39-44. [Abstract] [Full-text]
29. Ten years of skin malignancies in a single general practice.
    Dermatology, 210(1): 15-7. [Abstract] [Full-text]
30. Large cutaneous rabbit papillomas that persist during cyclosporin A treatment can regress spontaneously after cessation of immunosuppression.
    J Gen Virol, 86: 55-63. [Abstract] [Full-text]
31. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Cancer Res, 64(24): 9167-71. [Abstract] [Full-text]
32. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
    Cancer Res, 64(24): 8808-10. [Abstract] [Full-text]
33. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.
    Cancer Res, 64(24): 8804-7. [Abstract] [Full-text]
34. Carcinoma erysipelatoides resulting from gastric adenocarcinoma: an unusual clinical presentation.
    Med Princ Pract, 14(1): 61-3. [Abstract] [Full-text]
35. How I do it. In a pinch.
    Dermatol Surg, 30(12): 1599. [Abstract] [Full-text]
36. Refinement of the island pedicle flap: parallel placed release incisions to increase translation movement.
    Dermatol Surg, 30(12): 1595-8. [Abstract] [Full-text]
37. Back to basics: the subcutaneous island pedicle flap.
    Dermatol Surg, 30(12): 1587-90. [Abstract] [Full-text]
38. Modified vertical mattress technique for eyelid margin repair.
    Dermatol Surg, 30(12): 1580-2. [Abstract] [Full-text]
39. Mohs surgery for malignant eccrine neoplasms.
    Dermatol Surg, 30(12): 1574-9. [Abstract] [Full-text]
40. Surgical treatment of obstructive palpebral tumors in d'emblee variant of cutaneous T-cell lymphoma.
    Dermatol Surg, 30(12): 1568-71. [Abstract] [Full-text]
41. Myofibrosarcoma treated with Mohs micrographic surgery.
    Dermatol Surg, 30(12): 1565-7. [Abstract] [Full-text]
42. Localized cutaneous metastases from an atypical fibroxanthoma.
    Dermatol Surg, 30(12): 1561-4. [Abstract] [Full-text]
43. Pigmented speckling as a sign of basal cell carcinoma.
    Dermatol Surg, 30(12): 1553-5. [Abstract] [Full-text]
44. Morpheaform basal cell carcinoma in African Americans.
    Dermatol Surg, 30(12): 1550-2. [Abstract] [Full-text]
45. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
    Dermatol Surg, 30(12): 1546-9. [Abstract] [Full-text]
46. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Dermatol Surg, 30(12): 1543-5. [Abstract] [Full-text]
47. Acral malignant melanoma and striated palmoplantar keratoderma (Brunauer-Fohs-Siemens syndrome): a fortuitous association?
    Dermatol Surg, 30(12): 1539-42. [Abstract] [Full-text]
48. Local melanoma recurrence: a clarification of terminology.
    Dermatol Surg, 30(12): 1533-8. [Abstract] [Full-text]
49. Malignant melanoma arising in a pregnant African American woman with a congenital blue nevus.
    Dermatol Surg, 30(12): 1530-2. [Abstract] [Full-text]
50. Preparation of frozen sections.
    Dermatol Surg, 30(12): 1479-85. [Abstract] [Full-text]
51. Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers.
    Dermatol Surg, 30(12): 1470-8. [Abstract] [Full-text]
52. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Dermatol Surg, 30(12): 1462-9. [Abstract] [Full-text]
53. Indolent course of the cutaneous Hodgkin's disease.
    J Cutan Pathol, 32(2): 176-8. [Abstract] [Full-text]
54. Spiradenocylindrocarcinoma: a malignant hybrid tumor.
    J Cutan Pathol, 32(2): 166-71. [Abstract] [Full-text]
55. Merkel cell carcinoma in situ.
    J Cutan Pathol, 32(2): 162-5. [Abstract] [Full-text]
56. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
    J Cutan Pathol, 32(2): 148-57. [Abstract] [Full-text]
57. Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature.
    J Cutan Pathol, 32(2): 141-7. [Abstract] [Full-text]
58. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.
    J Cutan Pathol, 32(2): 131-6. [Abstract] [Full-text]
59. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
    J Cutan Pathol, 32(2): 125-30. [Abstract] [Full-text]
60. Melanoma or not? Cancer testis antigens may help.
    Br J Dermatol, 151(6): 1213-8. [Abstract] [Full-text]
61. Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
    Arch Dermatol, 140(12): 1504-7. [Abstract] [Full-text]
62. Vascular structures in skin tumors: a dermoscopy study.
    Arch Dermatol, 140(12): 1485-9. [Abstract] [Full-text]
63. Fewer melanocytic nevi found in children with active atopic dermatitis than in children without dermatitis.
    Arch Dermatol, 140(12): 1471-5. [Abstract] [Full-text]
64. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.
    J Invest Dermatol, 123(6): 1169-75. [Abstract] [Full-text]
65. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling.
    J Invest Dermatol, 123(6): 1151-61. [Abstract] [Full-text]
66. XAF1 expression is significantly reduced in human melanoma.
    J Invest Dermatol, 123(6): 1127-34. [Abstract] [Full-text]
67. UVB-induced apoptosis drives clonal expansion during skin tumor development.
    Carcinogenesis, 26(1): 249-57. [Abstract] [Full-text]
68. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
    Carcinogenesis, 26(1): 185-91. [Abstract] [Full-text]
69. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
    Carcinogenesis, 26(1): 119-24. [Abstract] [Full-text]
70. Diagnosis of melanoma in the elderly and surgical implications.
    Surg Oncol, 13(4): 211-21. [Abstract] [Full-text]
71. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries.
    Eur J Cancer, 41(1): 126-32. [Abstract] [Full-text]
72. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
    Eur J Cancer, 41(1): 118-25. [Abstract] [Full-text]
73. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
    Eur J Cancer, 41(1): 104-17. [Abstract] [Full-text]
74. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
    Eur J Cancer, 41(1): 45-60. [Abstract] [Full-text]
75. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
    Eur J Cancer, 41(1): 28-44. [Abstract] [Full-text]
76. Indoor tanning by adolescents: prevalence, practices and policies.
    Eur J Cancer, 41(1): 20-7. [Abstract] [Full-text]
77. Malignant melanoma with gall bladder metastasis as a second neoplasm in the course of prostate cancer.
    Pathol Oncol Res, 10(4): 243-5. [Abstract] [Full-text]
78. Imiquimod for the treatment of skin cancer.
    Dermatol Clin, 23(1): 151-64, vii. [Abstract] [Full-text]
79. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.
    Am J Med Genet A, 132(1): 49-53. [Abstract] [Full-text]
80. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
    Invest Ophthalmol Vis Sci, 46(1): 24-30. [Abstract] [Full-text]
81. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Clin Cancer Res, 10(24): 8396-404. [Abstract] [Full-text]
82. Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.
    Clin Cancer Res, 10(24): 8371-9. [Abstract] [Full-text]
83. Primary pleural epithelioid haemangioendothelioma with metastases to the skin. A case report and literature review.
    J Clin Pathol, 58(1): 107-9. [Abstract] [Full-text]
84. Subungual neurothekeoma.
    J Am Acad Dermatol, 52(1): 159-62. [Abstract] [Full-text]
85. Lethal basal cell carcinoma secondary to cerebral invasion.
    J Am Acad Dermatol, 52(1): 149-51. [Abstract] [Full-text]
86. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia.
    J Am Acad Dermatol, 52(1): 101-8. [Abstract] [Full-text]
87. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
    J Am Acad Dermatol, 52(1): 92-100. [Abstract] [Full-text]
88. Agminated acquired melanocytic nevi of the common and dysplastic type.
    J Am Acad Dermatol, 52(1): 67-73. [Abstract] [Full-text]
89. Melanoma detection in British Columbia, Canada.
    J Am Acad Dermatol, 52(1): 48-54. [Abstract] [Full-text]
90. Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection.
    J Am Acad Dermatol, 52(1): 40-7. [Abstract] [Full-text]

© 2004-2010 Skin Cancer Research Today. All Rights Reserved.